Merck opens €300m South Korea plant for regional biopharmaMembers
The 44,500-square-meter Daejeon facility produces dry cell culture media and process liquids to cut lead times for contract…
Company watch
All companies →Celltrion
Every EAB briefing that touches Celltrion — capital spending, plants, M&A, earnings and policy exposure. 2 briefings.
- First seen
- September 27, 2026
- Latest
- November 1, 2026
- With a linked document
- 2 of 2
- Subject of the briefing
- 2
- Desks
- Analysis (1), Semiconductors (1)
Commerce exempts South Korean biopharma from import tariffs on Sept. 29
New BIS rules grant zero-tariff entry for antibody-drug conjugates and cell therapies from 19 allied jurisdictions, shielding…